Ingevity (NGVT) executive compensation, 2026 proxy

David H. Li, President & Chief Executive Officer, was paid $12.8M in 2025. The CEO-to-median-employee pay ratio was 127:1, on median employee pay of $103,418.

Filed
March 17, 2026
Annual meeting
April 29, 2026
Pay year
2025
Named executives
7
CEO total pay
$12.8M2025
CEO to median employee
127:1median $103,418
CEO pay in equity
82%$10.5M in awards
CEO Salary
$810,685Annual base salary for David H. Li
CEO Stock Awards
$8,500,086Includes annual and sign-on RSUs and PSUs
CEO Option Awards
$2,000,007Sign-on option awards
CFO Total Pay
$1,993,143Total compensation for Mary Dean Hall

How Li was paid

$12.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary6%Stock awards66%Option awards16%Non-equity incentive10%All other compensation2%

Named executive officers

ExecutiveTotal
David H. LiPresident & Chief Executive Officer$12,839,719
Mary Dean HallEVP, Chief Financial Officer$1,993,143
Richard A. WhiteSVP & President, Performance Chemicals$1,601,163
Ryan C. FisherSVP, General Counsel & Corporate Secretary$1,220,246
Terry DyerSVP, Chief Human Resources Officer$1,190,927
Luis Fernandez-MorenoInterim President & Chief Executive Officer$1,065,486
S. Edward WoodcockEVP & President, Performance Materials$2,711,050

What changed and why

  • $12.8MDavid H. Li was appointed President and CEO effective April 7, 2025, receiving total compensation of $12,839,719 including sign-on equity awards.
  • $1.1MLuis Fernandez-Moreno served as interim CEO until April 7, 2025, earning total compensation of $1,065,486.
  • $2.7MS. Edward Woodcock departed the company on July 1, 2025, with total compensation of $2,711,050 including separation payments.
  • $2MMary Dean Hall served as EVP and CFO, receiving total compensation of $1,993,143 for 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.